Vacuolar H+-
adenosine triphosphatase (V-
ATPase) stimulates vesicular acidification that may activate cytoplasmic
enzymes,
hormone secretion and membrane recycling of transporters. We investigated the effect of blockade of V-
ATPase by
bafilomycin B1 on renal gluconeogenesis, mitochondrial
enzymes, and insulin secretion in type 2 diabetic rats. Spontaneous type 2 diabetic Torii rats were treated with
intraperitoneal injection of
bafilomycin B1 for 1 week, and the kidneys were examined after 24 h of
starvation in metabolic cages. The renal expression and activity of V-
ATPase were increased in the brush border membrane of the proximal tubules in diabetic rats. The blockade of V-
ATPase by
bafilomycin B1 reduced renal V-
ATPase activity and urinary
ammonium in diabetic rats. Treatment with bafilomycin suppressed the enhanced renal gluconeogenesis
enzymes and mitochondrial electron transport
enzymes in type 2 diabetic rats and reduced the renal cytoplasmic
glucose levels. The
insulin index and pancreatic
insulin granules were decreased in diabetic rats with increased V-
ATPase expression in islet cells, and treatment with
bafilomycin B1 reversed these changes and increased the insulin secretion index. Hepatosteatosis in type 2 diabetic rats was ameliorated by bafilomycin treatment. As a consequence, treatment with
bafilomycin B1 significantly decreased the plasma
glucose level after 24 h of
starvation in diabetic rats. In conclusion, a V-
ATPase inhibitor improved plasma
glucose levels in
type 2 diabetes by inhibiting renal mitochondrial gluconeogenesis and improving insulin secretion.